Published in Mol Cancer on March 10, 2010
PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate (2011) 2.13
Wnt/β-catenin signalling in prostate cancer. Nat Rev Urol (2012) 1.52
The many faces of neuroendocrine differentiation in prostate cancer progression. Front Oncol (2014) 1.43
WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res (2010) 1.19
MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One (2012) 1.17
Oncogenic activation of ERG: A predominant mechanism in prostate cancer. J Carcinog (2011) 1.13
Wnt signaling pathways in urological cancers: past decades and still growing. Mol Cancer (2012) 1.03
Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? Front Oncol (2015) 1.01
Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis. Int J Cancer (2014) 0.98
Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer. Am J Transl Res (2013) 0.96
Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prev Res (Phila) (2011) 0.96
Skeletal metastasis: treatments, mouse models, and the Wnt signaling. Chin J Cancer (2013) 0.95
Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers (Basel) (2011) 0.94
Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer. Prostate Cancer (2013) 0.94
Wnt signaling in castration-resistant prostate cancer: implications for therapy. Am J Clin Exp Urol (2014) 0.93
Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting. Am J Clin Exp Urol (2014) 0.91
Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev (2011) 0.90
Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges. J Carcinog (2012) 0.90
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal (2012) 0.87
Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. Int J Med Sci (2015) 0.86
Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system. Spermatogenesis (2013) 0.86
KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer. Mol Cancer Res (2014) 0.85
Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells. Biol Direct (2011) 0.82
Lentivirus-mediated Wnt11 gene transfer enhances Cardiomyogenic differentiation of skeletal muscle-derived stem cells. Mol Ther (2011) 0.82
Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure. Front Oncol (2015) 0.82
A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy. Transl Oncol (2013) 0.81
Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion. Sci Rep (2016) 0.78
Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer. Oncotarget (2016) 0.77
SOST Inhibits Prostate Cancer Invasion. PLoS One (2015) 0.76
miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells. Immunogenetics (2013) 0.76
Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability. Oncotarget (2016) 0.75
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories. Nat Commun (2017) 0.75
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. Cancers (Basel) (2017) 0.75
Ror2 Signaling and Its Relevance in Breast Cancer Progression. Front Oncol (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Wnt signalling and its impact on development and cancer. Nat Rev Cancer (2008) 8.37
Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation. Nature (2000) 5.52
Xwnt11 is a target of Xenopus Brachyury: regulation of gastrulation movements via Dishevelled, but not through the canonical Wnt pathway. Development (2000) 4.06
Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development (2003) 3.08
The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res (2008) 2.29
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res (2006) 2.02
Non-canonical Wnt signalling and regulation of gastrulation movements. Semin Cell Dev Biol (2002) 1.72
Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer (2007) 1.68
Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. Nat Genet (2007) 1.59
WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn (1999) 1.46
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol (1999) 1.43
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res (1999) 1.37
Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem Biophys Res Commun (2004) 1.36
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res (2008) 1.33
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res (2007) 1.33
Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ (2004) 1.30
Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J Biol Chem (2005) 1.30
Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J Biol Chem (2004) 1.27
Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene (2006) 1.26
Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem (2004) 1.22
Neuroendocrine differentiation in the progression of prostate cancer. Int J Urol (2009) 1.21
Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation (2008) 1.17
Neuroendocrine differentiation in prostate cancer: from lab to bedside. Urol Int (2007) 1.16
Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res (2004) 1.15
Wnt-11 is expressed in early avian mesoderm and required for the differentiation of the quail mesoderm cell line QCE-6. Development (1997) 1.03
Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells. Cancer Res (2007) 1.03
Pro-neural transcription factors as cancer markers. BMC Med Genomics (2008) 0.97
Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells. Exp Cell Res (2008) 0.92
A role for neurotensin in bicalutamide resistant prostate cancer cells. Prostate (2007) 0.89
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Mouse DNA contamination in human tissue tested for XMRV. Retrovirology (2010) 2.65
Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.44
The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A (2009) 2.29
Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol (2011) 2.20
Access to cancer drugs: local autonomy or local tyranny? Br J Hosp Med (Lond) (2008) 2.03
Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92
The management of gastric polyps. Gut (2010) 1.65
CD3 limits the efficacy of TCR gene therapy in vivo. Blood (2011) 1.55
Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene (2004) 1.54
Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol Cell Biol (2005) 1.52
Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol (2005) 1.42
Improving outcomes in early prostate cancer: Part II--neoadjuvant treatment. BJU Int (2006) 1.38
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res (2010) 1.31
Histological classification of ovarian cancer. Med Electron Microsc (2003) 1.30
Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem (2006) 1.29
Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene (2003) 1.24
Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene (2004) 1.16
Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res (2004) 1.15
Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther (2008) 1.14
What is tropical sprue? J Gastroenterol Hepatol (2003) 1.12
Hemodynamic responses in neural circuitries for detection of visual target and novelty: An event-related fMRI study. Hum Brain Mapp (2007) 1.07
Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol (2010) 1.06
The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth. J Neurochem (2010) 1.03
Crystal structures of an archaeal oligosaccharyltransferase provide insights into the catalytic cycle of N-linked protein glycosylation. Proc Natl Acad Sci U S A (2013) 1.02
Kinetic and structural studies on the catalytic role of the aspartic acid residue conserved in copper amine oxidase. Biochemistry (2006) 1.01
Structure of thiocyanate hydrolase: a new nitrile hydratase family protein with a novel five-coordinate cobalt(III) center. J Mol Biol (2006) 0.99
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J Biol Chem (2003) 0.99
Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett (2002) 0.99
Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan. Int J Urol (2012) 0.98
Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun (2005) 0.98
Purification and partial characterization of a Paracoccidioides brasiliensis protein with capacity to bind to extracellular matrix proteins. Infect Immun (2005) 0.98
Expression of surfactant protein D in the human gastric mucosa and during Helicobacter pylori infection. Infect Immun (2002) 0.97
Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res (2006) 0.97
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. Cancer Res (2010) 0.96
Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Eur J Cancer (2008) 0.96
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer. Int J Cancer (2012) 0.96
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours. Endocr Relat Cancer (2009) 0.95
Synthesis of melanin pigment by Candida albicans in vitro and during infection. Infect Immun (2005) 0.95
[Protein micro-crystallography with a new micro-beam beamline]. Yakugaku Zasshi (2010) 0.95
Structural basis for catalytic activation of thiocyanate hydrolase involving metal-ligated cysteine modification. J Am Chem Soc (2009) 0.95
Distinct roles for Wnt-4 and Wnt-11 during retinoic acid-induced neuronal differentiation. Stem Cells (2011) 0.93
Lymphocytic oesophagitis, a condition in search of a disease? Gut (2012) 0.93
Doctors should not discuss resuscitation with terminally ill patients: FOR. BMJ (2003) 0.92
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Res (2013) 0.91
Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer (2009) 0.91
Helicobacter pylori-associated hypochlorhydria in children, and development of iron deficiency. J Clin Pathol (2012) 0.91
Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Clin Cancer Res (2013) 0.91
Early chemotherapy in prostate cancer. Nat Clin Pract Urol (2008) 0.90
Crystal structure of the histidine-containing phosphotransfer protein ZmHP2 from maize. Protein Sci (2004) 0.90
Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice. J Pathol (2003) 0.89
Metabolic signatures of malignant progression in prostate epithelial cells. Int J Biochem Cell Biol (2010) 0.89
Clinical significance of heat shock protein-70 expression in bladder cancer. Urology (2003) 0.89
Visualising androgen receptor activity in male and female mice. PLoS One (2013) 0.89
A switch from canonical to noncanonical Wnt signaling mediates early differentiation of human neural stem cells. Stem Cells (2014) 0.89
The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6. Immunol Cell Biol (2010) 0.89
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors. J Biol Chem (2011) 0.88
A case of pregnancy complicated by the development of a tubo-ovarian abscess following in vitro fertilization and embryo transfer. Am J Perinatol (2003) 0.88
Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol (2013) 0.87
TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis. J Pathol (2011) 0.87
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival. J Pathol (2014) 0.87
Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-β/Smad signalling. J Cell Sci (2013) 0.87
Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report. J Med Case Rep (2012) 0.86
Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer. Nat Rev Urol (2011) 0.86
Mutational study on alphaGln90 of Fe-type nitrile hydratase from Rhodococcus sp. N771. Biosci Biotechnol Biochem (2006) 0.85
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer. Mol Endocrinol (2012) 0.85
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res (2014) 0.84
Elevated Serum Tissue Transglutaminase Antibodies in Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr (2017) 0.83
Emerging drugs for functional dyspepsia. Expert Opin Emerg Drugs (2015) 0.83
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol (2015) 0.83
Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study. PLoS One (2013) 0.83
Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor. Oncogene (2004) 0.82
No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population. Adv Virol (2011) 0.82
Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells. Biol Direct (2011) 0.82
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens. Clin Cancer Res (2004) 0.81
IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer. Clin Cancer Res (2009) 0.81
Nuclear export of alpha-catenin: overlap between nuclear export signal sequences and the beta-catenin binding site. Exp Cell Res (2004) 0.81
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Res Treat (2014) 0.81
Expression, purification, crystallization, and preliminary X-ray crystallographic studies of the human adiponectin receptors, AdipoR1 and AdipoR2. J Struct Funct Genomics (2015) 0.80
Gastric cancer and Helicobacter pylori: the bug, the host or the environment? Postgrad Med J (2008) 0.80
TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan. Eur J Immunol (2007) 0.80
Functional dyspepsia. Curr Opin Gastroenterol (2016) 0.80
Predictive ability of preoperative indices for esophagectomy. Thorac Surg Clin (2007) 0.79
Prostate cancer detection in men with a 'normal' total prostate-specific antigen (PSA) level using percentage free PSA: a prospective screening study. BJU Int (2005) 0.79